Skip to main content
. 2008 Mar 25;98(8):1434–1436. doi: 10.1038/sj.bjc.6604314

Table 1. Association between CASP8 variants D302H (rs1045485) and the ±6N promoter variant rs3834129 with colorectal cancer and results are also shown for the 8q24.21 variant rs6983267.

Gene/locus Variant Genotype Cases (%) Controls (%) OR (95% CI)
CASP8 D302H (rs1045485) CC 2890 (75%) 2703 (74%) 1.00 (ref)
    CG 894 (23%) 867 (24%) 1.09 (0.75–1.58)
    GG 59 (2%) 61 (2%) 1.13 (0.78–1.63)
    CG/GG 953 (25%) 928 (26%) 0.96 (0.86–1.07)
          Ptrend=0.67
           
CASP8 −/CTTACT (rs3834129)       Ptrend=0.97
    6N ins/ins 995 (26%) 892 (24%) 1.00
    6N del/ins 1897 (49%) 1872 (51%) 0.91 (0.81–1.01)
    6N del/del 987 (25%) 897 (25%) 0.99 (0.87–1.12)
    6Ndel/del +6N del/ins 2884 (74%) 2769 (76%) 0.93 (0.84–1.04)
          Ptrend=0.83
           
8q24.21 rs6983267 GG 1102 (31%) 678 (26%) 1.00 (ref)
    GT 1824 (51%) 1297 (50%) 0.86 (0.76–0.97)
    TT 657 (18%) 604 (23%) 0.67 (0.57–0.77)
    GT/TT 2481 (69%) 1901 (73%) 0.80 (0.72–0.90)
          Ptrend=1.13 × 10−6

Test of HWE: rs3834129, P=0.09; rs1045485, P=0.37; rs6983267, P=0.74. Crude odds ratios are presented. Ptrend, test of trend across genotypes. Adjustment for age and sex made no difference to metrics (data not shown).